Introduction: Chryseobacterium gleum is an uncommon pathogen in humans. It is a gram negative, nonfermenting bacterium distributed widely in soil and water. We present a case of urinary tract infection caused by Chryseobacterium gleum in a patient with right lower ureteric calculi. Case presentation: This case describes a 62- year-old male admitted for ureteric calculi to the Department of Urology in a tertiary care hospital in Kerala. A strain of Chryseobacterium gleum was isolated and confirmed by MALDI-TOF MS .The bacterium was sensitive to Piperacillin-Tazobactum (100/10µg ), Cefotaxime(30µg),Ceftazidime(30 µg ) and Ofloxacin(30 µg). It was resistant to Nitrofurantoin (300µg),Tobramycin(10µg),Gentamicin(30µg),Nalidixic acid(30µg) and Amikacin(30µg). Conclusion: Chryseobacterium gleum should be considered as a potential opportunistic and emerging pathogen. Resistance to a wide range of antibiotics such as aminoglycosides, penicillin, cephalosporins has been documented. In depth studies on Epidemiological, virulence and pathogenicity factors needs to be done for better diagnosis and management.
This study documents the first case of Chryseobacterium gleum associated UTI in South India.
Yabuuchi and E. Y. Hashimoto, "Ezaki Y.Ido Y,Takeuchi N.Genotypic and phenotypic differentiation of flavobacterium indologenes Yabuuchi et al. 1983 from flavobacterium gleum Holmes et al.1984 microbiol," Immunol., vol. 34, pp. 73-76, 1990.
G. Calderon, E. Garcia, P. Rojas, E. Garcia, M. Rosso, and A. Losada, "Chryseobacterium indologenes infection in a newborn: A case report," J. Med. Case Rep., vol. 5, p. 10, 2010.
P. Murray, M. Pfaller, F. Tenover, and R. Yolken, Manual of clinical microbiology, 6th ed. Washington, DC: ASM Press, 1995.
Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing :Twentieth Informational supplement M100-S20. Wayne,PA, USA: CLSI, 2010.
P. Vandamme, J. Bernardet, P. Segers, K. Kersters, and B. Holmes, "New perspectives in the classification of the flavobacteria: Description of chryseobacterium gen.nov. Bergeyella gen.nov., and empedobacter nom.rev," Int. J. Syst. Bacteriol., vol. 44, pp. 827-831, 1994.
E. Koneman, S. Allen, W. Janda, P. Schreckenberger, and J. Winn WC, The non fermentative Gram negative bacilli. In: Color atlas and textbook of diagnostic microbiology, 6th ed. Philadelphia: Lippincott, 1997.
J. Kirby, H. Sader, T. Walsh, and R. Jones, "Antimicrobial susceptibility and epidemiology of a worldwide collection of chryseobacterium spp: Report from the SENTRY antimicrobial surveillance program (1997-2001)," J. Clin. Microbiol., vol. 42, pp. 445-8, 2004.
V. Sudharani Asiya and N. Saxena, "Chryseobacterium indologenes bacteraemia in a preterm baby," Ind. J. Med. Microbiol., vol. 29, pp. 196-198, 2011.
S. Bellais, L. Poirel, S. Leotard, T. Naas, and P. Nordmann, "Genetic diversity of carbapenem-hydrolyzing metallo-b-lactamases from chryseobacterium N(Flavobacterium) indologenes," Antimicrob Agents Chemother, vol. 44, pp. 3028-3034, 2000.
G. Bhuyar, S. Jain, H. Shah, and V. Mehta, "Urinary tract infection by chryseobacterium indologenes," Indian J. Med. Microbiol., vol. 30, pp. 370-372, 2012.
P. Hsueh, L. Teng, P. Yang, S. Ho, W. Hsieh, and K. Luh, "Clinical and microbiological characteristics of flavobacterium indologenes infections associated with indwelling devices," J. Clin. Microbiol.1908–1913, p. 34, 1996.